Variant report
Variant | esv3437452 |
---|---|
Chromosome Location | chr6:102155009-102156107 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:102153395..102155355-chr6:102159822..102161608,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188795736 | chr6:102155041-102155042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73510682 | chr6:102155057-102155058 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs191422379 | chr6:102155071-102155072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532886184 | chr6:102155121-102155122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77102759 | chr6:102155165-102155166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73764508 | chr6:102155184-102155185 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs536681838 | chr6:102155288-102155289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7771050 | chr6:102155328-102155329 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs543407720 | chr6:102155337-102155338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201036760 | chr6:102155408-102155409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201755180 | chr6:102155411-102155412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200031147 | chr6:102155417-102155418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552239389 | chr6:102155418-102155419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs151005066 | chr6:102155427-102155428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530552125 | chr6:102155432-102155433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs56168617 | chr6:102155453-102155454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577712164 | chr6:102155454-102155455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs71984984 | chr6:102155458-102155459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs398002444 | chr6:102155469-102155470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201917715 | chr6:102155475-102155476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375549466 | chr6:102155477-102155478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368520499 | chr6:102155479-102155480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200108599 | chr6:102155481-102155482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537104737 | chr6:102155482-102155483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11757119 | chr6:102155483-102155484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534783797 | chr6:102155495-102155496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146698269 | chr6:102155561-102155562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572457262 | chr6:102155603-102155604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562105136 | chr6:102155622-102155623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558327626 | chr6:102155652-102155653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116162930 | chr6:102155725-102155726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569300515 | chr6:102155764-102155765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543857369 | chr6:102155809-102155810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562370621 | chr6:102155842-102155843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12215026 | chr6:102155905-102155906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1415481 | chr6:102155912-102155913 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs148384808 | chr6:102155966-102155967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559687725 | chr6:102155974-102155975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533388005 | chr6:102156021-102156022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551045398 | chr6:102156025-102156026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563069570 | chr6:102156049-102156050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530397709 | chr6:102156050-102156051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548719911 | chr6:102156051-102156052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548519426 | chr6:102156060-102156061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534617657 | chr6:102156063-102156064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73764509 | chr6:102156077-102156078 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs112835650 | chr6:102156106-102156107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Obesity | 21045960 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 22543975 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:102149400-102158000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr6:102154400-102155200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr6:102154800-102158000 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr6:102154800-102158000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr6:102155200-102170600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr6:102155800-102156000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr6:102156000-102157800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |